{"name":"Janssen-Cilag Ltd.","slug":"janssen-cilag-ltd","ticker":"","exchange":"","domain":"janssencilag.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":8,"colorKey":"cardiovascular","drugs":[{"name":"Rabeprazol","genericName":"Rabeprazol","slug":"rabeprazol","indication":"Duodenal Ulcer due to H. Pylori","status":"discontinued"},{"name":"JNJ-55308942 High Dose","genericName":"JNJ-55308942 High Dose","slug":"jnj-55308942-high-dose","indication":"Other","status":"phase_1"},{"name":"Risperidone prolonged release","genericName":"Risperidone prolonged release","slug":"risperidone-prolonged-release","indication":"Other","status":"marketed"},{"name":"TTS-fentanyl","genericName":"TTS-fentanyl","slug":"tts-fentanyl","indication":"Other","status":"marketed"},{"name":"Tacrolimus With Diet and Exercise Intervention","genericName":"Tacrolimus With Diet and Exercise Intervention","slug":"tacrolimus-with-diet-and-exercise-intervention","indication":"Other","status":"marketed"},{"name":"Vagitrol V","genericName":"Vagitrol V","slug":"vagitrol-v","indication":"Gastroesophageal reflux disease (GERD)","status":"phase_3"},{"name":"antipsychotic medications","genericName":"antipsychotic medications","slug":"antipsychotic-medications","indication":"Other","status":"phase_2"},{"name":"antipsychotics","genericName":"antipsychotics","slug":"antipsychotics","indication":"Other","status":"marketed"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":5,"colorKey":"infectious","drugs":[{"name":"Darunavir/Ritonavir (DRV/r)","genericName":"Darunavir/Ritonavir (DRV/r)","slug":"darunavir-ritonavir-drv-r","indication":"HIV-1 infection in treatment-experienced patients","status":"phase_3"},{"name":"Efavirenz (EFV)","genericName":"Efavirenz (EFV)","slug":"efavirenz-efv","indication":"HIV-1 infection (in combination with other antiretroviral agents)","status":"marketed"},{"name":"Gynoclin V","genericName":"Gynoclin V","slug":"gynoclin-v","indication":"Bacterial vaginosis","status":"phase_3"},{"name":"TMC114/ritonavir","genericName":"TMC114/ritonavir","slug":"tmc114-ritonavir","indication":"HIV-1 infection in treatment-experienced patients","status":"marketed"},{"name":"darunavir (DRV, TMC114)","genericName":"darunavir (DRV, TMC114)","slug":"darunavir-drv-tmc114","indication":"Treatment of HIV-1 infection in adults and children","status":"phase_3"}]},{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"immunology","drugs":[{"name":"Galantamine (Reminyl)","genericName":"Galantamine (Reminyl)","slug":"galantamine-reminyl","indication":"Mild to moderate Alzheimer's disease","status":"marketed"},{"name":"double blind PR OROS methylphenidate","genericName":"double blind PR OROS methylphenidate","slug":"double-blind-pr-oros-methylphenidate","indication":"Attention deficit hyperactivity disorder (ADHD)","status":"phase_3"},{"name":"Oxybutinin Extended-Release","genericName":"Oxybutinin Extended-Release","slug":"oxybutinin-extended-release","indication":"Overactive bladder with symptoms of urge incontinence, urgency, and frequency","status":"marketed"},{"name":"open label PR OROS methylphenidate","genericName":"open label PR OROS methylphenidate","slug":"open-label-pr-oros-methylphenidate","indication":"Attention deficit hyperactivity disorder (ADHD)","status":"phase_3"}]},{"name":"Pain","slug":"pain","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"neuroscience","drugs":[{"name":"Tramadol HCI/acetaminophen","genericName":"Tramadol HCI/acetaminophen","slug":"tramadol-hci-acetaminophen","indication":"Moderate to moderately severe pain","status":"marketed"},{"name":"OROS hydromorphone HCl","genericName":"OROS hydromorphone HCl","slug":"oros-hydromorphone-hcl","indication":"Moderate to severe chronic pain requiring continuous opioid therapy","status":"marketed"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Fentanyl-TTS","genericName":"Fentanyl-TTS","slug":"fentanyl-tts","indication":"Chronic pain in opioid-tolerant patients","status":"marketed"}]}],"pipeline":[{"name":"Fentanyl-TTS","genericName":"Fentanyl-TTS","slug":"fentanyl-tts","phase":"marketed","mechanism":"Fentanyl-TTS is a transdermal patch that delivers the opioid fentanyl through the skin at a controlled rate to provide long-acting pain relief.","indications":["Chronic pain in opioid-tolerant patients","Cancer pain","Severe chronic pain requiring opioid therapy"],"catalyst":""},{"name":"Galantamine (Reminyl)","genericName":"Galantamine (Reminyl)","slug":"galantamine-reminyl","phase":"marketed","mechanism":"Galantamine inhibits acetylcholinesterase to increase acetylcholine levels in the brain, and also acts as an allosteric modulator of nicotinic receptors to enhance cholinergic neurotransmission.","indications":["Mild to moderate Alzheimer's disease"],"catalyst":""},{"name":"Rabeprazol","genericName":"Rabeprazol","slug":"rabeprazol","phase":"discontinued","mechanism":"Sterile alpha and TIR motif-containing protein 1, ATP-binding cassette sub-family G member 2, Adenosine receptor A3","indications":["Duodenal Ulcer due to H. Pylori","Duodenal ulcer disease","Gastroesophageal reflux disease","Maintenance of Healing Gastroesophageal Reflux","Multiple endocrine adenomas"],"catalyst":""},{"name":"Tramadol HCI/acetaminophen","genericName":"Tramadol HCI/acetaminophen","slug":"tramadol-hci-acetaminophen","phase":"marketed","mechanism":"Tramadol inhibits norepinephrine and serotonin reuptake while weakly binding opioid receptors, while acetaminophen inhibits prostaglandin synthesis to provide combined analgesic and antipyretic effects.","indications":["Moderate to moderately severe pain"],"catalyst":""},{"name":"double blind PR OROS methylphenidate","genericName":"double blind PR OROS methylphenidate","slug":"double-blind-pr-oros-methylphenidate","phase":"phase_3","mechanism":"Methylphenidate is a central nervous system stimulant that works by increasing the levels of dopamine and norepinephrine in the brain.","indications":["Attention deficit hyperactivity disorder (ADHD)"],"catalyst":""},{"name":"Darunavir/Ritonavir (DRV/r)","genericName":"Darunavir/Ritonavir (DRV/r)","slug":"darunavir-ritonavir-drv-r","phase":"phase_3","mechanism":"Darunavir is a protease inhibitor that blocks HIV protease, preventing viral polyprotein cleavage and maturation, while ritonavir acts as a pharmacokinetic booster to increase darunavir levels.","indications":["HIV-1 infection in treatment-experienced patients","HIV-1 infection in treatment-naïve patients"],"catalyst":""},{"name":"Efavirenz (EFV)","genericName":"Efavirenz (EFV)","slug":"efavirenz-efv","phase":"marketed","mechanism":"Efavirenz inhibits HIV reverse transcriptase, blocking the enzyme that converts viral RNA into DNA and preventing HIV replication.","indications":["HIV-1 infection (in combination with other antiretroviral agents)"],"catalyst":""},{"name":"Gynoclin V","genericName":"Gynoclin V","slug":"gynoclin-v","phase":"phase_3","mechanism":"Gynoclin V is a clindamycin-based vaginal formulation that inhibits bacterial protein synthesis to treat vaginal infections.","indications":["Bacterial vaginosis","Vaginal infections caused by susceptible bacteria"],"catalyst":""},{"name":"JNJ-55308942 High Dose","genericName":"JNJ-55308942 High Dose","slug":"jnj-55308942-high-dose","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"OROS hydromorphone HCl","genericName":"OROS hydromorphone HCl","slug":"oros-hydromorphone-hcl","phase":"marketed","mechanism":"OROS hydromorphone HCl is an extended-release opioid agonist that binds to mu-opioid receptors in the central nervous system to provide sustained pain relief.","indications":["Moderate to severe chronic pain requiring continuous opioid therapy"],"catalyst":""},{"name":"Oxybutinin Extended-Release","genericName":"Oxybutinin Extended-Release","slug":"oxybutinin-extended-release","phase":"marketed","mechanism":"Oxybutynin is an anticholinergic agent that blocks muscarinic acetylcholine receptors in the bladder smooth muscle, reducing involuntary contractions and increasing bladder capacity.","indications":["Overactive bladder with symptoms of urge incontinence, urgency, and frequency","Neurogenic detrusor overactivity in spinal cord injury patients"],"catalyst":""},{"name":"Risperidone prolonged release","genericName":"Risperidone prolonged release","slug":"risperidone-prolonged-release","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"TMC114/ritonavir","genericName":"TMC114/ritonavir","slug":"tmc114-ritonavir","phase":"marketed","mechanism":"TMC114 (darunavir) is a protease inhibitor that blocks HIV protease, preventing viral replication when boosted with ritonavir.","indications":["HIV-1 infection in treatment-experienced patients","HIV-1 infection in treatment-naïve patients"],"catalyst":""},{"name":"TTS-fentanyl","genericName":"TTS-fentanyl","slug":"tts-fentanyl","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Tacrolimus With Diet and Exercise Intervention","genericName":"Tacrolimus With Diet and Exercise Intervention","slug":"tacrolimus-with-diet-and-exercise-intervention","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Vagitrol V","genericName":"Vagitrol V","slug":"vagitrol-v","phase":"phase_3","mechanism":"Vagitrol V is a medication that works by inhibiting the action of a specific enzyme.","indications":["Gastroesophageal reflux disease (GERD)","Erosive esophagitis"],"catalyst":""},{"name":"antipsychotic medications","genericName":"antipsychotic medications","slug":"antipsychotic-medications","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"antipsychotics","genericName":"antipsychotics","slug":"antipsychotics","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"darunavir (DRV, TMC114)","genericName":"darunavir (DRV, TMC114)","slug":"darunavir-drv-tmc114","phase":"phase_3","mechanism":"Darunavir is a protease inhibitor that blocks the protease enzyme in HIV, preventing viral replication.","indications":["Treatment of HIV-1 infection in adults and children","Prevention of HIV-1 infection in adults and children"],"catalyst":""},{"name":"open label PR OROS methylphenidate","genericName":"open label PR OROS methylphenidate","slug":"open-label-pr-oros-methylphenidate","phase":"phase_3","mechanism":"Methylphenidate is a central nervous system stimulant that works by increasing the levels of dopamine and norepinephrine in the brain.","indications":["Attention deficit hyperactivity disorder (ADHD)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxQYUUxb2huVFNMOW9qMzBtcndGMXcydC11NHR6Y1hPU3k1SkJYTUdKNmZlLXpnVWMzanBfcmJjRjNwZXdfMXNCWG45LUJ0akxlYlBMZEwwaGhLX2RtaGZnaFh0WEFkUlJ0ajlCTkJMWmhCc0xaeUl5SEN1and3YWZWd3YweEtyN3BranpKazdnX3pGX0pfNkNHbUM2YWw?oc=5","date":"2026-02-20","type":"patent","source":"JUVE Patent","summary":"BMS and Johnson & Johnson battle over novel CAR-T cell therapy in Europe - JUVE Patent","headline":"BMS and Johnson & Johnson battle over novel CAR-T cell therapy in Europe","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxOTDI0QXVXalpabWF3bm9PNlA2WGhTT2k0TkxXQkM5dHpyY21ySUJ2Z1NMTnVuc01WZThJbWU5QS1yRWhlYzRWX1NvR0F2V1NIZmF2XzhlMFoyOGMtb29iX1FQc0ZZSTJ2SlYxRmYwLUdBZFZtZG9qN2ZwSVpOSnAyMVBfcW1mWHZ1WEdrMkhURXBaLXZFTXA2cllmWlNocWxzNXVxSzdVbEI?oc=5","date":"2026-02-19","type":"patent","source":"JUVE Patent","summary":"No claim to damages for Millenium and Cilag in dispute over bortezomib - JUVE Patent","headline":"No claim to damages for Millenium and Cilag in dispute over bortezomib","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1wFBVV95cUxQbHFuMTFKc0Zpd29fXzZiQ0JVc2ViRGYxM2V4RnU3VmdrTlFkdEdNdlZzX2pJX2RkZ2h2ZkxCOF91NEgwd21zWVlTNUpPX3ZGSnlQdnVIbUl2X3dIcWdOTE1NczYzTjItSUVhTmExcVRjWHg0WE9jenN4ZVJRQmZhYW1QeUlzQVRkeFhWY2tDcjZ5VlNOSGxuUkFNS1dsY0RJdXpFZEEzal8zNmdjT0pMV0Q4Wi16czJLM1BjcUtJYzZFTXZzVUhJTVpqTjBpVVhXRndGamE2NA?oc=5","date":"2025-12-17","type":"patent","source":"Pearce IP","summary":"Federal Court of Australia Awards Janssen First Pharmaceutical Patent Preliminary Injunction in 7 Years - Pearce IP","headline":"Federal Court of Australia Awards Janssen First Pharmaceutical Patent Preliminary Injunction in 7 Years","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxOY2Ewc09mVzF5V29uUFdUemJUTFB1RUw3RE5KbU91M3Z2WUhBTXhWLTA5US0wV2JUSl82REpDUHpMN3dwaXBmXzRCRXlPOTlnZWUxMEo1QlNDcC1DTm51czJqVWtaVVRkNlNhbk5yRjRYMW41MzUxTG5jY0x6X1o2dzJDdVdUOHFpbzJpcEFMUHJtVnVEZFBrOXl0TdIBVkFVX3lxTE1pbXpVNjZUbTdEbUxsUWJoNDB3YnpUcGRiSkhXVVd4MFducktYY2FNdHo1YXNRYW14RWEwRzNhRV94T2tFQXRKRzNqVmg2alVvYkZlcFJR?oc=5","date":"2025-11-24","type":"patent","source":"Law360","summary":"Advanz Challenges Janssen Patents On Schizophrenia Drug - Law360","headline":"Advanz Challenges Janssen Patents On Schizophrenia Drug - Law360","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-10-01","type":"patent","source":"The Hindu","summary":"Lupin launches generic of Janssen Pharma’s VTE drug in U.S. - The Hindu","headline":"Lupin launches generic of Janssen Pharma’s VTE drug in U.S.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxQYmtIbEtRV1J1bmFfRHdETjc5bW85SnlfZWQ0MU83aU41cXI5WWxLTXhpWmp1elhkMlBpMjFiM0ZSNkpxNEhFT25zY0FtLVprNEdWRGtBUGVjNzJ0Mk0wT0VoRGJaZ0p5ZkI2UVpyWmNtZ2FBX3JoejFtWmJuV29vU1paZWJCdE1GaFhNejdRVkc2cFpaVUE?oc=5","date":"2025-06-02","type":"pipeline","source":"Psychiatrist.com","summary":"What Is Meant by the Term “Deprescribing,” and Does It Belong in Our Lexicon? - Psychiatrist.com","headline":"What Is Meant by the Term “Deprescribing,” and Does It Belong in Our Lexicon?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-AFBVV95cUxNQ2lsbVgwbGdiZDBfTlRzMXhnVTNLWlJrR2ZRcGRwQ3JveDluVEF6X08wc3JRd1lobzhFR3kyREFoa1pKNGFFY3dxeFJfa1ZpZzd0MUd3cGZvQVpVY2dqMFVCVWhkcTRmR0tVaWRWNWpfbzVkVzRZdUFCd0UyWG83TjVWYTBvRFFlVFJMeUplMEtxZ3NEdFlkdXlYaHRNTlAxR3plMFdDVXh2THU4dE5NdGRZTm85SHhRak83MzhTWHJ1NWM5OUR2aXNfSFpWS1R5R3Q1QUJ1alQyeE5pa3RjRnI5SjgyVjFQWENvSjhOLWIxZ3FCbm9SWg?oc=5","date":"2024-04-19","type":"deal","source":"Pharmaceutical Executive","summary":"Essential Pharma Acquires Reminyl, a Cholinesterase Inhibitor to Treat Mild to Moderately Severe Dementia from Janssen Pharmaceutica NV - Pharmaceutical Executive","headline":"Essential Pharma Acquires Reminyl, a Cholinesterase Inhibitor to Treat Mild to Moderately Severe Dementia from Janssen P","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE5FVVUza1JtTEVxUWtEaGxHRkg0Ym82Um5QbE5GLXVjZGMtZkZ2QzN2ZUlYaGc4XzM4YTFCeHZLb1dLNGdTVU1ZZFhOTUxKVjVzZnZnczEtekRMSVBRNmtXQW5qejlsdUFYWkZLTnJVRHplbDlLMkwtVy1zNEg?oc=5","date":"2024-04-18","type":"deal","source":"Pharmaceutical Technology","summary":"Essential Pharma acquires Reminyl from Janssen Pharmaceutica - Pharmaceutical Technology","headline":"Essential Pharma acquires Reminyl from Janssen Pharmaceutica","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTFA3UkF4T1E0ZGpxTldxZXl0Q01nLXUzLTZVcDI5bklaV3J6cGZ0c2VjNVJ4U09xalhJOXNCMWw5T1ZsbXE4Nml3TFlRaXNnZlpObjFEekJLd2ZIbmRUcVhITEQzalJWWWtWMGc?oc=5","date":"2021-02-23","type":"pipeline","source":"Wiley Online Library","summary":"Journal of the European Academy of Dermatology and Venereology - Wiley Online Library","headline":"Journal of the European Academy of Dermatology and Venereology","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE9OREdvdjVoNURMTmRvWGpRSDJSWUQ2bXZ2Y0g2ajF0RjVsV1NkdmZlYmVuTndJQnVxYUoxUzFoSnBqYVY2UHowN005ejlBaVBBY3ljbTctQm43VlJkampv?oc=5","date":"2019-12-19","type":"trial","source":"Nature","summary":"Valuable data from Alzheimer's clinical trial made available to researchers - Nature","headline":"Valuable data from Alzheimer's clinical trial made available to researchers","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywJBVV95cUxPZnZMNWM3VXVQcVVFYUVpZjByR0xBaVZGakRycTkzbDVRMHlLbnBmelpQWjdKNGpqNEhQcDB4N1c1ZnUxWmR0aWtzU3dJbWR6d2ZCY0d2VXUtNjlrSWtqakxnYkZYNGhXbGl5YmZhLUZMOHVUU1ZYV2tJbXFTd1dfWkNWVENrNGlKekswNE9ZbzA4Vlh0amVSTlJyQlJkQXl4dnhtRXVIVHB4QTVfTC1BRW5xY194c0NGWWJ6THZGMDZQQ1JCWl92VzNKdUxLVFlkbE91VDliX0lnWWJvV2dPdUt0NVNCNU84UmZFT1Z2dlVZWXNOdjl0NHUwWkQwalg0RFNSVVRhSk43WmpNa3diaThUQmRHeGd5WHE3Zm1YWDZqN3Nlc3pqZGduWFJJaHpKLWNJWnBQamJOdURHTDlIUkZiRTlTZ19nY0tv?oc=5","date":"2018-10-04","type":"deal","source":"PR Newswire","summary":"Janssen Announces Exclusive, Worldwide License Agreement With Arrowhead Pharmaceuticals to Develop and Commercialize a New Treatment for Chronic Hepatitis B Viral Infection - PR Newswire","headline":"Janssen Announces Exclusive, Worldwide License Agreement With Arrowhead Pharmaceuticals to Develop and Commercialize a N","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxQc3l6Q1UxQ1VsdG0wd1RacktoVThZdzN3bW9XSVZuRThSa2thT0FibHVtNlF0TExCVTUzQ21MMGdxdXNGei1nRjhlN2VWeHpIbXd4RzQxLXFXUVRQZDZzVVMxYnVjc2pXc1FWRDF1MGh4cnRiRmFSZTY5Q1ZBQW1pYnBqVGlyUlE5MnVCNUk5eGJlMTF4NkhUREhMSGJiMlNKTFJ5clBNQzdzempPN1BV?oc=5","date":"2015-09-11","type":"pipeline","source":"Johnson & Johnson","summary":"The legacy of Dr. Paul Janssen: How a “funny idea” helped change the course of modern medicine - Johnson & Johnson","headline":"The legacy of Dr. Paul Janssen: How a “funny idea” helped change the course of modern medicine - Johnson & Johnson","sentiment":"neutral"}],"patents":[],"drugCount":20,"phaseCounts":{"marketed":11,"discontinued":1,"phase_3":6,"phase_1":1,"phase_2":1},"enrichmentLevel":2,"visitCount":6,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}